DÄ internationalArchive5/2007Peyronie's Disease – a Hidden Problem

Review article

Peyronie's Disease – a Hidden Problem

Dtsch Arztebl 2007; 104(5): A-263

Klotz, T; Mathers, M J; Sommer, F

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. De La Peyronie F: Sur Quelsques obstacles qui sópposent a léjaculation naturelle de la semance. Med Aca R Chir 1743; 1: 425.
2. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U: The prevalence of Peyronie´s disease: results of a large survey. BJU Int 2001; 88: 727–30. MEDLINE
3. Mulhall JP, Creecj SD, Bpprjian SA et al.: Subjective and objective analysis of the prevalence of Peyronie´s disease in a population of men presenting for prostate cancer screening. J Urol 2004; 171: 2350–3. MEDLINE
4. Kadioglu A, Oktar T, Kandirali E et al.: Incidentally diagnosed Peyronies´s disease in men presenting with erektile dysfunction. Int J Impot Res 2004; 16: 540–3. MEDLINE
5. Shabsigh R, Fleming M, Pereman M, Anastasiadis A: Peyronies´s Disease Index (PDI); a standardized patients questionaire. Int J Impot Res 2003; 14(Suppl. 5): 568.
6. Usta MF, Bivalacque TJ, Jabren GW et al.: Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronies´s disease. J Urol 2004; 171: 775–9. MEDLINE
7. Shah M, Foreman DM, Ferguson MW: Controlling of scaring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 1992; 339: 213–4. MEDLINE
8. El-Sakka AI, Hassoba HM, Chui RM et al.: An animal model of Peyronie´s-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol 1997; 158: 2284–90. MEDLINE
9. Mulhull JP: Expanding the paradigm for plaque development in Peyronie´s disease. Int J Impot Res 2003;15(Suppl. 5): 93–102.
10. Hauck EW, Diemer T, Weidner W: Induratio penis plastica. Urologe 2006; 45: 243–59.
11. Hauck EW, Weidner W: Francois de la Peyronie and the disease named alter him. Lancet 2001; 357: 2049–51. MEDLINE
12. Weidner W, Hauck EW, Schnitker J: Potassium paraaminobenzoate (Potaba TM) in the treatment of Peyronies´s disease: A prospective, placebo-controlled, randomized study. Eur Urol 2005; 47: 530–6. MEDLINE
13. Scott WW, Scardino PL: New concept in the treatment of Peyronie´s disease. South Med J 1999; 41: 173.
14. Levine LA: Treatment of Peyronie´s disease with intralesional verapamil injections. J Urol 1997; 158: 1395–97. MEDLINE
15. Hellstrom WJ, Kendirci M, Matern R, Cokerham Y, Myers L, Sikka SC, Venable D, Honig S, McCullough A, Hakim LS, Nehra A, Templeton LE, Pryor JL: Single-blind multicenter, placebo controlled, parallel study to assess safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie`s disease. J Urol 2006; 176: 394–8. MEDLINE
16. Hauck EW, Mueller UO, Bschleipfer T, Schmelz HU, Diemer T, Weidner W: Extracorporal shock wave therapy for Peyronie`s disease: exploratory meta- analysis of clinical trials. J Urol 2004; 171: 740–5. MEDLINE
17. Levine LA, Lenting EL: A surgical algorithm for the treatment of Peyronie´s disease. J Uro 1997; 58: 2149–52. MEDLINE
18. Nesbit RM: Congenital curvature of the phallus: report of three cases with discription of corrective operation. J Urol 1965; 93: 230–2. MEDLINE
19. Essed E, Schroeder FH: New surgical treatment for Peyronie´s disease. Urology 1985; 25: 582. MEDLINE
20. Lue TF, El-Sakka Al: Venous patch graft for Peyronie´s disease. Part I. J Urol 1998; 160: 2047–9. MEDLINE
21. Kadioglu A, Akman T, Sanli O, Gurkan L, Cakan M, Celtik M: Surgical treatment of Peyronie`s disease: a critical analysis. Eur Urol 2006; 50: 235–48. MEDLINE